UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer

Clinical biochemistry, 2019-02, Vol.64, p.60-63

2019

Volltextzugriff (PDF)

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma

Neoplasia (New York, N.Y.), 2020-12, Vol.22 (12), p.800-808

2020

Volltextzugriff (PDF)

Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML

Frontiers in oncology, 2022-02, Vol.12, p.841608-841608

2022

Volltextzugriff (PDF)

Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia

Cancers, 2019-10, Vol.11 (11), p.1625

2019

Volltextzugriff (PDF)

Adaptation of the Hydrocarbonoclastic Bacterium Alcanivorax borkumensis SK2 to Alkanes and Toxic Organic Compounds: a Physiological and Transcriptomic Approach

Applied and Environmental Microbiology, 2013-07, Vol.79 (14), p.4282-4293

2013

Volltextzugriff (PDF)

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

Journal of hematology and oncology, 2022-05, Vol.15 (1), p.60-60, Article 60

2022

Volltextzugriff (PDF)

High Potential for Anaerobic Microbial Sulfur Oxidation in Oil Sands Tailings Ponds

Microorganisms (Basel), 2021-12, Vol.9 (12), p.2529

2021

Volltextzugriff (PDF)

Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer

Frontiers in genetics, 2022-01, Vol.12, p.811291-811291

2022

Volltextzugriff (PDF)

Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence

NPJ digital medicine, 2024-03, Vol.7 (1), p.76-76, Article 76

2024

Volltextzugriff (PDF)

Point Mutations in the FLT3 -ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A -PTD

Frontiers in oncology, 2022-03, Vol.12, p.862991-862991

2022

Volltextzugriff (PDF)

PB1759: RETAINED FUNCTIONAL NORMAL AND/OR PRE‐LEUKEMIC HSCS IN THE BONE MARROW ARE ASSOCIATED TO GOOD PROGNOSIS IN DNMT3AMUTNPM1MUT AML PATIENTS

HemaSphere, 2023-08, Vol.7 (S3), p.e06701e1-n/a

2023

Volltextzugriff (PDF)

S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA

HemaSphere, 2023-08, Vol.7 (S3), p.e72156a7-n/a

2023

Volltextzugriff (PDF)

Interaction of microbial sulphate reduction and methanogenesis in oil sands tailings ponds

Chemosphere (Oxford), 2014-05, Vol.103, p.59-66

2014

Volltextzugriff (PDF)

Vertical gradients in carbon flow and methane production in a sulfate-rich oil sands tailings pond

Water research (Oxford), 2016-12, Vol.106, p.223-231

2016

Volltextzugriff (PDF)

Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia

Blood advances, 2018-06, Vol.2 (11), p.1187-1190

2018

Volltextzugriff (PDF)

CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

Blood, 2022-01, Vol.139 (1), p.87-103

2022

Volltextzugriff (PDF)

TERT promoter mutation detection in cell-free tumor-derived DNA in patients with IDH wild-type glioblastomas - a pilot prospective study

Clinical cancer research, 2018-11, Vol.24 (21), p.5282-5291

2018

Volltextzugriff (PDF)

Anaerobic BTEX degradation in oil sands tailings ponds: Impact of labile organic carbon and sulfate-reducing bacteria

Chemosphere (Oxford), 2015-11, Vol.138, p.133-139

2015

Volltextzugriff (PDF)

Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association

Leukemia, 2019-01, Vol.33 (1), p.26-36

2019

Volltextzugriff (PDF)

Mimicking Clinical Trials with Synthetic Acute Myeloid Leukemia Patients Using Generative Artificial Intelligence

Blood, 2023-11, Vol.142 (Supplement 1), p.2268-2268

2023

Volltextzugriff (PDF)

Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy

Current treatment options in oncology, 2020-01, Vol.21 (1), p.8-8, Article 8

2020

Volltextzugriff (PDF)

Understanding biogeochemical gradients of sulfur, iron and carbon in an oil sands tailings pond

Chemical geology, 2014-08, Vol.382, p.44-53

2014

Volltextzugriff (PDF)

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma12

Neoplasia (New York, N.Y.), 2020-11, Vol.22 (12), p.800-808

2020

Volltextzugriff (PDF)

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification

Leukemia, 2023-11, Vol.37 (11), p.2282-2285

2023

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(55)
Buchkapitel
(1)

Sprache

Englisch
(56)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(35)
Hematology
(19)
Oncology
(17)
Mutation
(13)
Humans
(12)
Leukemia
(10)
Prognosis
(10)
Acute Myeloid Leukemia
(9)
Leukemia, Myeloid, Acute - Genetics
(8)
Patients
(6)
Hematopoietic Stem Cells
(5)
Leukemia, Myeloid, Acute - Diagnosis
(5)
Oil Sands Tailings Ponds
(5)
Adult
(4)
Aml
(4)
Bacteria
(4)
Environmental Sciences & Ecology
(4)
Methanogenesis
(4)
Nucleophosmin
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma

Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML

Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia

Adaptation of the Hydrocarbonoclastic Bacterium Alcanivorax borkumensis SK2 to Alkanes and Toxic Organic Compounds: a Physiological and Transcriptomic Approach

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

High Potential for Anaerobic Microbial Sulfur Oxidation in Oil Sands Tailings Ponds

Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer

Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence

Point Mutations in the FLT3 -ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A -PTD

PB1759: RETAINED FUNCTIONAL NORMAL AND/OR PRE‐LEUKEMIC HSCS IN THE BONE MARROW ARE ASSOCIATED TO GOOD PROGNOSIS IN DNMT3AMUTNPM1MUT AML PATIENTS

S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA

Interaction of microbial sulphate reduction and methanogenesis in oil sands tailings ponds

Vertical gradients in carbon flow and methane production in a sulfate-rich oil sands tailings pond

Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia

CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

TERT promoter mutation detection in cell-free tumor-derived DNA in patients with IDH wild-type glioblastomas - a pilot prospective study

Anaerobic BTEX degradation in oil sands tailings ponds: Impact of labile organic carbon and sulfate-reducing bacteria

Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association

Mimicking Clinical Trials with Synthetic Acute Myeloid Leukemia Patients Using Generative Artificial Intelligence

Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy

Understanding biogeochemical gradients of sulfur, iron and carbon in an oil sands tailings pond

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma12

Overlapping features of therapy-related and de novo NPM1-mutated AML

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification

Suchergebnisse filtern